Index of reports
> All Cases (59)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Thiotepa (Thiotepa Intracavitary) all cases. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 59 Next >>
Possible Thiotepa side effects in 9 year old female
Reported by a physician from Israel on 2012-07-27
Patient: 9 year old female
Reactions: Transplant Failure, Post Transplant Lymphoproliferative Disorder, Guillain-Barre Syndrome, Pericarditis, Pleural Effusion
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Busulfex
Dosage: 3.2 mg/kg, daily dose, days 9 to 6, intravenous
Indication: Bone Marrow Conditioning Regimen
Anti-Thymocyte Globulin Rabbit NOS
Dosage: 2.5 mg/kg/d on days -4 to (10mg/kg); 2.5 mg/kg/d on days - 4 to -2
Indication: Bone Marrow Conditioning Regimen
Fludarabine Phosphate
Dosage: 30 mg/m2/d on days 0 to -5 (180mg/m^2); 40 mg/d/d on days -5 to -3
Indication: Bone Marrow Conditioning Regimen
Thiotepa
Dosage: 5mg/kg/d on days; 8 mg/kg/d on day - 7
Indication: Bone Marrow Conditioning Regimen
Other drugs received by patient: Azathioprine (Azathioprine0; Treosulfan (Treosulfan); Acyclovir; Hydroxyurea; Cyclosporine
Possible Thiotepa side effects in female
Reported by a individual with unspecified qualification from United States on 2012-06-28
Patient: female, weighing 13.2 kg (29.0 pounds)
Reactions: Vomiting, Malaise, Diarrhoea, Febrile Neutropenia, Somnolence, Eating Disorder, Cough
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 476 mg
End date: 2012-06-12
Thiotepa
Dosage: 280 mg
End date: 2012-06-12
Possible Thiotepa side effects in female
Reported by a individual with unspecified qualification from United States on 2012-06-27
Patient: female, weighing 13.2 kg (29.0 pounds)
Reactions: Vomiting, Parainfluenzae Virus Infection, Diarrhoea, Hypophagia, Decreased Activity, Fluid Intake Reduced, Febrile Neutropenia, Hypersomnia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Thiotepa
Dosage: 280 mg
End date: 2012-06-12
Carboplatin
Dosage: 476 mg
End date: 2012-06-12
Possible Thiotepa side effects in 4 year old male
Reported by a physician from Israel on 2012-06-14
Patient: 4 year old male
Reactions: Generalised Oedema, Polyserositis, Pericardial Effusion, Ascites, Periorbital Oedema, Weight Increased, Oedema Peripheral, Pleural Effusion
Drug(s) suspected as cause:
Fludarabine Phosphate
Indication: Prophylaxis Against Transplant Rejection
Atgam
Indication: Prophylaxis Against Transplant Rejection
Busulfan
Indication: Prophylaxis Against Transplant Rejection
Cyclophosphamide
Indication: Prophylaxis Against Transplant Rejection
Thiotepa
Indication: Prophylaxis Against Transplant Rejection
Possible Thiotepa side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-17
Patient:
Reactions: Nephropathy Toxic, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Valaciclovir
Indication: Antiviral Prophylaxis
Rabbit Antithymocyte Immu (Formulation Unknown) (Rabbit Antithymocyte
Indication: Haematological Malignancy
Melphalan Hydrochloride
Dosage: 140 mg/m2/
Indication: Haematological Malignancy
Fludarabine Phosphate
Dosage: 160 mg/m2/
Indication: Haematological Malignancy
Levofloxacin
Indication: Antibiotic Prophylaxis
Thiotepa
Dosage: 10 mg/kg/
Indication: Haematological Malignancy
Possible Thiotepa side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-17
Patient:
Reactions: Pancreatitis Acute
Drug(s) suspected as cause:
Levofloxacin
Indication: Antibiotic Prophylaxis
Thiotepa
Dosage: 10 mg/kg/
Indication: Haematological Malignancy
Fludarabine Phosphate
Dosage: 160 mg/m2/
Indication: Haematological Malignancy
Valaciclovir
Indication: Antiviral Prophylaxis
Melphalan Hydrochloride
Dosage: 140 mg/m2/
Indication: Haematological Malignancy
Rabbit Antithymocyte Immu (Formulation Unknown) (Rabbit Antithymocyte
Indication: Haematological Malignancy
Possible Thiotepa side effects in male
Reported by a consumer/non-health professional from United States on 2012-05-17
Patient: male
Reactions: Dialysis, Nephropathy Toxic, Renal Failure Acute
Drug(s) suspected as cause:
Rabbit Antithymocyte Immu (Formulation Unknown) (Rabbit Antithymocyte
Indication: Haematological Malignancy
Valaciclovir
Indication: Antiviral Prophylaxis
Fludarabine Phosphate
Dosage: 160 mg/mg
Indication: Haematological Malignancy
Levofloxacin
Indication: Antibiotic Prophylaxis
Melphalan Hydrochloride
Dosage: 140 mg/m2
Indication: Haematological Malignancy
Thiotepa
Dosage: 10 mg/kg
Indication: Haematological Malignancy
Possible Thiotepa side effects in male
Reported by a physician from United States on 2012-04-24
Patient: male, weighing 12.1 kg (26.6 pounds)
Reactions: Neutropenic Colitis, Acidosis, Caecitis, Barotrauma, Ascites, Mucosal Inflammation, Acute Lung Injury, Acute Respiratory Failure
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Thiotepa
Dosage: 510 mg
Cyclophosphamide
Dosage: 3360 mg
Possible Thiotepa side effects in male
Reported by a physician from Germany on 2012-04-23
Patient: male, weighing 14.8 kg (32.6 pounds)
Reactions: Peritonitis Bacterial, Sepsis, Neutropenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Fludara
Indication: Stem Cell Transplant
Treosulfan
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-09-06
End date: 2011-09-12
Treosulfan
Indication: Stem Cell Transplant
Thiotepa
Indication: Stem Cell Transplant
Anti-Thymocyte Globulin Equine NOS
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-09-06
End date: 2011-09-12
Clofarabine
Dosage: 44 mg/m2, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-08-10
End date: 2011-08-14
Fludara
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-09-06
End date: 2011-09-12
Etopophos Preservative Free
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-08-10
End date: 2011-08-14
Cyclophosphamide
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-08-10
End date: 2011-08-14
Thiotepa
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-09-06
End date: 2011-09-12
Anti-Thymocyte Globulin Equine NOS
Indication: Stem Cell Transplant
Other drugs received by patient: Acyclovir; Amikacin; Zyvox; Granocyte; Cyclosporine; Amikacin; Acyclovir; Tigecycline; Zyvox; Prednisolone; Granocyte; Tigecycline
Possible Thiotepa side effects in 3 year old
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-04-17
Patient: 3 year old
Reactions: Respiratory Failure, Pneumomediastinum, Acute Respiratory Distress Syndrome, Pneumothorax
Adverse event resulted in: death
Drug(s) suspected as cause:
Carboplatin
Dosage: unk
Indication: Medulloblastoma
Cyclophosphamide
Dosage: unk
Indication: Medulloblastoma
Etoposide
Dosage: unk
Indication: Medulloblastoma
Thiotepa
Dosage: unk
Indication: Medulloblastoma
Possible Thiotepa side effects in 65 year old male
Reported by a physician from United States on 2012-04-17
Patient: 65 year old male
Reactions: Encephalitis Cytomegalovirus, Graft Versus Host Disease, Central Nervous System Lesion, Panencephalitis, CNS Ventriculitis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Thiotepa
Indication: Diffuse Large B-Cell Lymphoma
Thiotepa
Indication: Myeloid Leukaemia
Thiotepa
Indication: Myelodysplastic Syndrome
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Indication: Myeloid Leukaemia
Rituximab
Indication: Myelodysplastic Syndrome
Idarubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Idarubicin HCL
Indication: Myelodysplastic Syndrome
Idarubicin HCL
Indication: Myeloid Leukaemia
Fludarabine Phosphate
Indication: Diffuse Large B-Cell Lymphoma
Fludarabine Phosphate
Indication: Myelodysplastic Syndrome
Fludarabine Phosphate
Indication: Myeloid Leukaemia
Etoposide
Indication: Diffuse Large B-Cell Lymphoma
Etoposide
Indication: Myelodysplastic Syndrome
Etoposide
Indication: Myeloid Leukaemia
Valaciclovir
Indication: Myeloid Leukaemia
Valaciclovir
Indication: Cytomegalovirus Infection
Valaciclovir
Indication: Myelodysplastic Syndrome
Depocyt
Indication: Diffuse Large B-Cell Lymphoma
Depocyt
Indication: Myelodysplastic Syndrome
Depocyt
Indication: Myeloid Leukaemia
Mitoxantrone
Indication: Myelodysplastic Syndrome
Mitoxantrone
Indication: Myeloid Leukaemia
Mitoxantrone
Indication: Diffuse Large B-Cell Lymphoma
Anti-Thymocyte Globulin Equine NOS
Indication: Diffuse Large B-Cell Lymphoma
Anti-Thymocyte Globulin Equine NOS
Indication: Myelodysplastic Syndrome
Anti-Thymocyte Globulin Equine NOS
Indication: Myeloid Leukaemia
Foscarnet
Indication: Myelodysplastic Syndrome
Foscarnet
Indication: Cytomegalovirus Infection
Foscarnet
Indication: Myeloid Leukaemia
Acyclovir
Indication: Myeloid Leukaemia
Acyclovir
Indication: Cytomegalovirus Infection
Acyclovir
Indication: Myelodysplastic Syndrome
Possible Thiotepa side effects in 3 year old
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-04-12
Patient: 3 year old
Reactions: Respiratory Failure, Pneumomediastinum, Hypercapnia, Pneumothorax, Acute Respiratory Distress Syndrome, Platelet Count Decreased
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Medulloblastoma
Etoposide
Indication: Medulloblastoma
Carboplatin
Indication: Medulloblastoma
Thiotepa
Indication: Medulloblastoma
Possible Thiotepa side effects in
Reported by a health professional (non-physician/pharmacist) from France on 2012-04-11
Patient:
Reactions: Stem Cell Transplant, Pulmonary Alveolar Haemorrhage
Adverse event resulted in: death
Drug(s) suspected as cause:
Melphalan Hydrochloride
Dosage: 140 mg/m2
Indication: Neuroblastoma
Busulfan
Dosage: 600 mg/m2
Indication: Neuroblastoma
Thiotepa
Dosage: 300 mg/m2 / per day
Indication: Neuroblastoma
Possible Thiotepa side effects in 3 year old
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-04-10
Patient: 3 year old
Reactions: Respiratory Failure
Adverse event resulted in: death
Drug(s) suspected as cause:
Thiotepa
Indication: Medulloblastoma
Cyclophosphamide
Indication: Medulloblastoma
Etoposide
Indication: Medulloblastoma
Carboplatin
Indication: Medulloblastoma
Possible Thiotepa side effects in 3 year old
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-04-06
Patient: 3 year old
Reactions: Respiratory Failure
Adverse event resulted in: death
Drug(s) suspected as cause:
Etoposide
Indication: Medulloblastoma
Carboplatin
Indication: Medulloblastoma
Thiotepa
Indication: Medulloblastoma
Cyclophosphamide
Indication: Medulloblastoma
Possible Thiotepa side effects in 6 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-02
Patient: 6 year old female
Reactions: Pneumonia, Abscess Fungal, Mental Status Changes, Renal Abscess, Pyrexia, Convulsion, Stem Cell Transplant, Encephalitis Cytomegalovirus, Graft Versus Host Disease in Skin, Sepsis, Hydrocephalus, CNS Ventriculitis
Adverse event resulted in: death
Drug(s) suspected as cause:
Methylprednisolone
Dosage: not reported, unknown, unknown
Indication: Graft Versus Host Disease
Anti-Thymocyte Globulin Equine NOS
Dosage: not reported, unknown, unknown
Indication: Acute Lymphocytic Leukaemia Recurrent
Cytarabine
Dosage: not reported, unknown, unknown
Indication: Acute Lymphocytic Leukaemia Recurrent
Therapeutic Radiopharmaceuticals
Dosage: not reported, unknown, other
Indication: Acute Lymphocytic Leukaemia Recurrent
Thiotepa
Dosage: not reported, unknown, unknown
Indication: Acute Lymphocytic Leukaemia Recurrent
Immune Globulin NOS
Dosage: not reported, unknown, unknown
Indication: Acute Lymphocytic Leukaemia Recurrent
Ganciclovir
Dosage: 12 mg/kg, unknown, unknown
Indication: Cytomegalovirus Viraemia
Corticosteroids
Dosage: not reported, unknown, unknown
Indication: Acute Lymphocytic Leukaemia Recurrent
Cidofovir
Dosage: two doses, unknown, unknown
Indication: Cytomegalovirus Viraemia
Foscarnet Sodium
Dosage: 90 mg/kg, unknown, unknown
Indication: Cytomegalovirus Viraemia
Monoclonal Antibodies
Dosage: not reported, unknown, unknown
Indication: Graft Versus Host Disease
Possible Thiotepa side effects in 65 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-30
Patient: 65 year old male
Reactions: Encephalitis Cytomegalovirus, CNS Ventriculitis
Adverse event resulted in: death
Drug(s) suspected as cause:
Cytarabine
Dosage: not reported, unknown, unknown
Indication: Myelodysplastic Syndrome
Cytarabine
Dosage: not reported, unknown, unknown
Indication: Diffuse Large B-Cell Lymphoma
Cytarabine
Dosage: not reported, unknown, unknown
Indication: Acute Myeloid Leukaemia
Idarubicin HCL
Dosage: not reported, unknown, unknown
Indication: Myelodysplastic Syndrome
Idarubicin HCL
Dosage: not reported, unknown, unknown
Indication: Diffuse Large B-Cell Lymphoma
Valaciclovir
Dosage: not reported, unknown, unknown
Indication: Cytomegalovirus Viraemia
Etoposide
Dosage: not reported, unknown, unknown
Indication: Myelodysplastic Syndrome
Etoposide
Dosage: not reported, unknown, unknown
Indication: Diffuse Large B-Cell Lymphoma
Acyclovir
Dosage: not reported, unknown, unknown
Indication: Cytomegalovirus Viraemia
Rituximab
Dosage: not reported, unknown, unknown
Indication: Myelodysplastic Syndrome
Rituximab
Dosage: not reported, unknown, unknown
Indication: Diffuse Large B-Cell Lymphoma
Foscarnet Sodium
Dosage: not reported, unknown, unknown
Indication: Cytomegalovirus Viraemia
Mitoxantrone Hydrochloride
Dosage: not reported, unknown, unknown
Indication: Diffuse Large B-Cell Lymphoma
Mitoxantrone Hydrochloride
Dosage: not reported, unknown, unknown
Indication: Myelodysplastic Syndrome
Anti-Thymocyte Globulin Equine NOS
Dosage: not reported, unknown, unknown
Indication: Myelodysplastic Syndrome
Anti-Thymocyte Globulin Equine NOS
Dosage: not reported, unknown, unknown
Indication: Acute Myeloid Leukaemia
Anti-Thymocyte Globulin Equine NOS
Dosage: not reported, unknown, unknown
Indication: Diffuse Large B-Cell Lymphoma
Fludarabine Phosphate
Dosage: not reported, unknown, unknown
Indication: Diffuse Large B-Cell Lymphoma
Fludarabine Phosphate
Dosage: not reported, unknown, unknown
Indication: Myelodysplastic Syndrome
Fludarabine Phosphate
Dosage: not reported, unknown, unknown
Indication: Acute Myeloid Leukaemia
Therapeutic Radiopharmaceuticals
Dosage: not reported, unknown, other
Indication: Diffuse Large B-Cell Lymphoma
Therapeutic Radiopharmaceuticals
Dosage: not reported, unknown, other
Indication: Myelodysplastic Syndrome
Thiotepa
Dosage: not reported, unknown, unknown
Indication: Myelodysplastic Syndrome
Thiotepa
Dosage: not reported, unknown, unknown
Indication: Acute Myeloid Leukaemia
Thiotepa
Dosage: not reported, unknown, unknown
Indication: Diffuse Large B-Cell Lymphoma
Possible Thiotepa side effects in 3 year old
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-03-29
Patient: 3 year old
Reactions: Respiratory Failure, Pneumomediastinum, Acute Respiratory Distress Syndrome, Pneumothorax
Adverse event resulted in: death, disablity
Drug(s) suspected as cause:
Etoposide
Dosage: hit 2000 met-bis4 protocol
Indication: Medulloblastoma
Thiotepa
Dosage: hit 2000 met-bis4 protocol
Indication: Medulloblastoma
Cyclophosphamide
Dosage: hit 2000 met-bis4 protocol
Indication: Medulloblastoma
Carboplatin
Dosage: hit 2000 met-bis4 protocol
Indication: Medulloblastoma
Possible Thiotepa side effects in 3 year old
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-03-29
Patient: 3 year old
Reactions: Respiratory Failure, Acute Respiratory Distress Syndrome
Adverse event resulted in: death, disablity
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: hit 2000 met-bis4 protocol
Indication: Medulloblastoma
Carboplatin
Dosage: hit 2000 met-bis4 protocol
Indication: Medulloblastoma
Etoposide
Dosage: hit 2000 met-bis4 protocol
Indication: Medulloblastoma
Thiotepa
Dosage: hit 2000 met-bis4 protocol
Indication: Medulloblastoma
Possible Thiotepa side effects in 3 year old
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-03-27
Patient: 3 year old
Reactions: Death, Respiratory Failure, Hypercapnia, Pneumomediastinum, Acute Respiratory Distress Syndrome, Pneumothorax
Adverse event resulted in: death
Drug(s) suspected as cause:
Carboplatin
Indication: Medulloblastoma
Thiotepa
Indication: Medulloblastoma
Cyclophosphamide
Indication: Medulloblastoma
Etoposide
Indication: Medulloblastoma
Possible Thiotepa side effects in 3 year old
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-03-22
Patient: 3 year old
Reactions: Death, Respiratory Failure, Hypercapnia, Pneumomediastinum, Acute Respiratory Distress Syndrome, Pneumothorax
Adverse event resulted in: death
Drug(s) suspected as cause:
Thiotepa
Indication: Medulloblastoma
Cyclophosphamide
Indication: Medulloblastoma
Etoposide
Indication: Medulloblastoma
Carboplatin
Indication: Medulloblastoma
Possible Thiotepa side effects in male
Reported by a individual with unspecified qualification from France on 2012-03-15
Patient: male, weighing 13.1 kg (28.7 pounds)
Reactions: Mucosal Inflammation, Vomiting, Diarrhoea, Hypotonia, Quadriparesis, Decreased Appetite, Tremor
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ondansetron HCL
Indication: Vomiting
Start date: 2011-11-02
Thiotepa
Dosage: cyclic / intravenous
Indication: Brain Neoplasm Malignant
Start date: 2011-10-30
End date: 2011-11-01
Carboplatin
Dosage: cyclic / intravenous
Indication: Brain Neoplasm Malignant
Start date: 2011-10-27
End date: 2011-10-29
Alizapride Hydrochloride (Formulation Unknown) (Alizapride Hydrochlori
Indication: Vomiting
Start date: 2011-11-02
Ceftazidime Sodium
Dosage: 430 mg / three times per day
Indication: Product Used FOR Unknown Indication
Start date: 2011-11-02
Kabiven
Indication: Enteral Nutrition
Start date: 2011-11-02
Vancomycin HCL
Dosage: 135 mg / four times per day
Indication: Product Used FOR Unknown Indication
Start date: 2011-11-02
Possible Thiotepa side effects in male
Reported by a physician from France on 2012-03-08
Patient: male, weighing 13.1 kg (28.8 pounds)
Reactions: Hypotonia, Quadriparesis, Tremor
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Kabiven
Indication: Enteral Nutrition
Start date: 2011-11-02
Carboplatin
Dosage: 289mg per day
Indication: Brain Neoplasm Malignant
Start date: 2011-10-27
End date: 2011-10-29
Plitican
Indication: Vomiting
Start date: 2011-11-02
Zofran
Indication: Vomiting
Start date: 2011-11-02
Ceftazidime
Dosage: 430mg three times per day
Indication: Product Used FOR Unknown Indication
Start date: 2011-11-02
Vancomycin
Dosage: 135mg four times per day
Indication: Product Used FOR Unknown Indication
Start date: 2011-11-02
Thiotepa
Dosage: 170mg per day
Indication: Brain Neoplasm Malignant
Start date: 2011-10-30
End date: 2011-11-01
Other drugs received by patient: Stem Cell Transplant
Possible Thiotepa side effects in 4 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-02-23
Patient: 4 year old male
Reactions: Fluid Overload, Jaundice, Pulmonary Veno-Occlusive Disease, Refractoriness To Platelet Transfusion, Neutropenic Sepsis, Pyrexia, Ascites, Haematemesis, Weight Increased, Mucosal Inflammation, Hepatomegaly, Malaise, Tachypnoea, Hypoxia, Pleural Effusion
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Bone Marrow Conditioning Regimen
(Alemtuzumab)
Busulfan
Dosage: tablet 14 mg/kg
Methotrexate
Thiotepa
Indication: Bone Marrow Conditioning Regimen
Cyclosporine
Indication: Prophylaxis Against Graft Versus Host Disease
Possible Thiotepa side effects in female
Reported by a physician from United States on 2012-02-17
Patient: female, weighing 10.4 kg (22.9 pounds)
Reactions: Neutropenic Colitis, Respiratory Failure, Post Procedural Complication, Pulmonary Oedema, Septic Shock
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
G-CSF (Filgrastim, Amgen)
Dosage: 357mcg
Thiotepa
Dosage: 210 mg
Carboplatin
Dosage: 356 mg
Possible Thiotepa side effects in 56 year old male
Reported by a physician from Norway on 2012-02-06
Patient: 56 year old male
Reactions: Cerebral Haemorrhage
Adverse event resulted in: death
Drug(s) suspected as cause:
Carboplatin
Dosage: 7x(gfr+25) mg daily, cyclic (day1-4)
Indication: Testis Cancer
Cyclophosphamide
Dosage: 1500 mg/m2 daily, cyclic (day 1-4)
Indication: Testis Cancer
Thiotepa
Dosage: 120 mg/m2 daily, cyclic (day 1-4)
Indication: Testis Cancer
Possible Thiotepa side effects in male
Reported by a physician from United Kingdom on 2012-02-02
Patient: male
Reactions: Venoocclusive Disease, Cytomegalovirus Infection, Acidosis, Pneumonia Cytomegaloviral
Adverse event resulted in: death
Drug(s) suspected as cause:
Thiotepa
Indication: Bone Marrow Conditioning Regimen
Cyclosporine
Indication: Prophylaxis Against Graft Versus Host Disease
Busulfan
Dosage: 14mgk unknown
Indication: Bone Marrow Conditioning Regimen
Methotrexate
Indication: Prophylaxis Against Graft Versus Host Disease
Cyclophosphamide
Dosage: 200mgk unknown
Indication: Bone Marrow Conditioning Regimen
Alemtuzumab
Indication: Bone Marrow Conditioning Regimen
Possible Thiotepa side effects in 65 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-01-23
Patient: 65 year old male
Reactions: Multi-Organ Failure, Lung Disorder
Adverse event resulted in: death
Drug(s) suspected as cause:
Busulfan
Indication: Bone Marrow Conditioning Regimen
Start date: 2011-12-02
End date: 2011-12-04
Cyclophosphamide
Indication: Bone Marrow Conditioning Regimen
Start date: 2011-12-05
End date: 2011-12-06
Thiotepa
Indication: Bone Marrow Conditioning Regimen
Start date: 2011-11-29
End date: 2011-12-01
Mesna
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-05
End date: 2011-12-06
Other drugs received by patient: Clonazepam
Possible Thiotepa side effects in 48 year old male
Reported by a health professional (non-physician/pharmacist) from Spain on 2012-01-19
Patient: 48 year old male
Reactions: Dermatitis, Metaplasia, Oedema, Erythema
Drug(s) suspected as cause:
Carboplatin
Indication: Bone Marrow Transplant
Cyclophosphamide
Indication: Bone Marrow Transplant
Thiotepa
Indication: Bone Marrow Transplant
Possible Thiotepa side effects in female
Reported by a physician from Japan on 2012-01-12
Patient: female, weighing 20.0 kg (44.0 pounds)
Reactions: Stomatitis, Alanine Aminotransferase Increased, Sepsis, Bone Marrow Failure, Bacterial Infection, Pyrexia, Decreased Appetite, Infection
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Alkeran
Dosage: 50mgm2 per day
Start date: 2008-09-17
End date: 2008-09-18
Thiotepa
Dosage: 150mgm2 per day
Start date: 2008-09-17
End date: 2008-09-18
Thiotepa
Dosage: 150mgm2 per day
Indication: Stem Cell Transplant
Start date: 2008-09-10
End date: 2008-09-11
Alkeran
Dosage: 50mgm2 per day
Indication: Stem Cell Transplant
Start date: 2008-09-10
End date: 2008-09-11
Other drugs received by patient: Immune Globulin Intravenous (Human); Meropenem; High-Calorie Transfusion Fluid; Immune Globulin (Human); Neupogen; Neutrogin; Cefpirome; Tobramycin; Prodif
Page 1 Next >>
|